Searched for
LUPIN DRUGS
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- Suryoday Small Finance Bank reports Q4 profit at Rs 49 croreSuryoday Small Finance Bank reported a strong turnaround in fourth-quarter earnings with improved profitability and higher operating profit...
- Obesity drug market to gain as Indians pop the pill and Chinese bring moreIndia's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...
- Lupin launches generic anti-diabetic tablets in USPharma major Lupin has launched its generic anti-diabetic medicine in the United States. The medicine is dapagliflozin and metformin hydroc...
- Time to buy? Sunny Agrawal finds best picks across banking, pharma, capital markets & infrastructureIndian stock markets present attractive opportunities now. Investors with an 18-month outlook should consider deploying funds, especially i...
- Mounjaro sales dip amid price war as semaglutide generics gain groundMounjaro, the star pharmaceutical from Eli Lilly, is experiencing a downturn in sales across India. This slump can be attributed to competi...
- Lupin gets tentative nod from USFDA for generic Sugammadex injectionLupin Ltd, a prominent name in the pharmaceutical world, revealed on Tuesday that it has gained tentative approval from the US health autho...
- GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy genericsIndian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and...
- Lupin gets USFDA nod for biosimilar drugLupin gets USFDA approval for Armlupeg, a biosimilar to Neulasta, to treat neutropenia in cancer patients. The drug will be manufactured at...
- Lupin arm gets supplemental new drug application approval from US regulator for SolosecThe drug was approved in the US in 2017 for the treatment of bacterial vaginosis in adult women, the company said.
- Lupin launches generic HIV-1 drug in USThe drug maker's product is the generic version of Gilead Sciences, Inc's Truvada tablets and indicated in combination with other antiretro...
- Lupin launches generic antibiotic inhalation solution in USThe company has launched the product as it has received an approval from the US Food and Drug Administration (USFDA) earlier, Lupin said in...
- Lupin to challenge Pregabalin ruling by US courtLupin Limited says it will challenge a US court order that prevents it from selling a low-cost generic version of Pfizer's nerve pain drug ...
- Lupin launches Generic Diabetes drugIndian pharmaceutical major Lupin launched the generic version of Watson’s Fortamet despite an impeding patent suit against Lupin in the US.
- Novo sues Lupin to block generic in USDanish company Novo Nordisk has sued Mumbai-based drugmaker Lupin to prevent it from launching the low priced version of its patented diabe...
- Lupin gets US FDA nod for anti-depressantPharma major Lupin on Tuesday said it has received final approval from the US health regulator for its anti-depression drug Imipramine Pamo...
Load More
